Doo-Hun Kim
Patrimonio netto: 149 502 $ in data 31/05/2026
Patrimonio netto: 149 502 $ in data 31/05/2026
Doo-Hun Kim currently works at Feyman Asset Management Co., Ltd., as Chief Executive Officer and AbClon, Inc., as Chief Financial Officer & Executive Director from 2024.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ABCLON, INC. 0,03% | 27/04/2026 | 6.000 ( 0,03% ) | 149 502 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ABCLON INC. | Direttore Finanziario/CFO | 28/03/2024 |
Feyman Asset Management Co., Ltd.
Feyman Asset Management Co., Ltd. Investment ManagersFinance FAM is an active, GARP-oriented, team-based investment manager which concentrates on high-performance stock in the electronics, finance, chemical, iron/steel manufacturing and transportation equipment manufacturing industries. The firm primarily manages stock/bond combination funds and money market funds. They apply a combination of bottom-up and top-down approaches in the composition of portfolios, and consider both value and growth firms. In addition, industry-specific analysis takes up an important role, while risk management is achieved through sector-rotating and evaluation against a benchmark. | Amministratore Delegato | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 2 |
|---|---|
Feyman Asset Management Co., Ltd.
Feyman Asset Management Co., Ltd. Investment ManagersFinance FAM is an active, GARP-oriented, team-based investment manager which concentrates on high-performance stock in the electronics, finance, chemical, iron/steel manufacturing and transportation equipment manufacturing industries. The firm primarily manages stock/bond combination funds and money market funds. They apply a combination of bottom-up and top-down approaches in the composition of portfolios, and consider both value and growth firms. In addition, industry-specific analysis takes up an important role, while risk management is achieved through sector-rotating and evaluation against a benchmark. | Finance |
AbClon, Inc.
AbClon, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of antibody drugs | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale